Retinoid isomerase inhibitors impair but do not block mammalian cone photoreceptor function by Kiser, Philip D et al.




Retinoid isomerase inhibitors impair but do not
block mammalian cone photoreceptor function
Philip D. Kiser
Case Western Reserve University
Jianye Zhang
Case Western Reserve University
Aditya Sharma




Washington University School of Medicine in St. Louis
See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Kiser, Philip D.; Zhang, Jianye; Sharma, Aditya; Angueyra, Juan M.; Kolesnikov, Alexander V.; Badiee, Mohsen; Tochtrop, Gregory P.;
Kinoshita, Junzo; Peachey, Neal S.; Li, Wei; Kefalov, Vladimir J.; and Palczewski, Krzysztof, ,"Retinoid isomerase inhibitors impair but
do not block mammalian cone photoreceptor function." Journal of General Physiology.150,4. 571. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/6758
Authors
Philip D. Kiser, Jianye Zhang, Aditya Sharma, Juan M. Angueyra, Alexander V. Kolesnikov, Mohsen Badiee,
Gregory P. Tochtrop, Junzo Kinoshita, Neal S. Peachey, Wei Li, Vladimir J. Kefalov, and Krzysztof Palczewski
This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/6758
R E S E A RCH A RTI CLE
https://doi.org/10.1085/jgp.201711815 571
J. Gen. Physiol. 2018 Vol. 150 No. 4 571–590
Rockefeller University Press
Visual function in vertebrates critically depends on the continuous regeneration of visual pigments in rod and cone 
photoreceptors. RPE65 is a well-established retinoid isomerase in the pigment epithelium that regenerates rhodopsin 
during the rod visual cycle; however, its contribution to the regeneration of cone pigments remains obscure. In this study, 
we use potent and selective RPE65 inhibitors in rod- and cone-dominant animal models to discern the role of this enzyme 
in cone-mediated vision. We confirm that retinylamine and emixustat-family compounds selectively inhibit RPE65 over 
DES1, the putative retinoid isomerase of the intraretinal visual cycle. In vivo and ex vivo electroretinography experiments 
in Gnat1−/− mice demonstrate that acute administration of RPE65 inhibitors after a bleach suppresses the late, slow 
phase of cone dark adaptation without affecting the initial rapid portion, which reflects intraretinal visual cycle function. 
Acute administration of these compounds does not affect the light sensitivity of cone photoreceptors in mice during 
extended exposure to background light, but does slow all phases of subsequent dark recovery. We also show that cone 
function is only partially suppressed in cone-dominant ground squirrels and wild-type mice by multiday administration 
of an RPE65 inhibitor despite profound blockade of RPE65 activity. Complementary experiments in these animal models 
using the DES1 inhibitor fenretinide show more modest effects on cone recovery. Collectively, these studies demonstrate 
a role for continuous RPE65 activity in mammalian cone pigment regeneration and provide further evidence for RPE65-
independent regeneration mechanisms.
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Introduction
Light perception by the vertebrate eye begins with a cis-to-trans 
photoisomerization of the retinylidene chromophore of photore-
ceptor cell visual pigments. This geometric change converts the 
opsin protein component of these pigments to an active signal-
ing state, which is capable of initiating the phototransduction 
cascade with consequent changes in second messenger levels 
and plasma membrane potentials. In this way, a light stimulus 
is converted to an electrical signal, which is propagated to the 
brain for interpretation of the visual world. Photoreceptor sig-
naling is sustained by a regeneration process that carries out the 
light-independent, endergonic conversion of trans-retinoid back 
to an 11-cis configuration, a pathway known as the retinoid or 
visual cycle (Saari, 2012; Kiser et al., 2014). The classic version 
of this pathway involves chemical transformations occurring 
in the retinal pigment epithelium (RPE) that are critical for the 
regeneration of rod visual pigments (Fig. 1; Kuhne, 1878). In this 
pathway, all-trans-retinaldehyde released from bleached visual 
pigments is converted to vitamin A, which is trapped in the RPE 
through the action of an esterifying enzyme called lecithin-reti-
nol acyltransferase (LRAT; Saari and Bredberg, 1989). These ret-
inyl esters serve as substrates for the membrane-bound enzyme 
RPE65 (RPE-specific 65-kD protein), which cleaves and isom-
erizes them to form 11-cis-retinol (Redmond et al., 1998). This 
cis-retinoid is further oxidized and then shuttled back to photo-
receptor outer segments, where it combines with free opsins to 
form ground state pigments poised for subsequent light activa-
tion (Palczewski, 2006).
A conundrum exists regarding the role of RPE65 in cone 
visual pigment regeneration. On the one hand, the severely 
attenuated cone electroretinography (ERG) responses in Rpe65 
knockout mice (Redmond et al., 1998; Seeliger et al., 2001; Maeda 
et al., 2009) as well as humans (Jacobson et al., 2007, 2009) and 
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dogs (Acland et al., 2005) with loss of function RPE65 muta-
tions, together with the apparent lack of cone pigment forma-
tion in Nrl−/−Rpe65−/− mice (Wenzel et al., 2007; Feathers et al., 
2008), suggest that RPE65 is an essential component of the cone 
pigment regeneration pathway, as is the enrichment of RPE65 
expression and function in the cone-rich foveal region of the 
primate retina (Jacobson et al., 2007). Data showing enhanced 
isomerase activity for RPE65 from the cone-dominant chicken 
compared with orthologues from rod-dominant rodent species 
also suggest a mechanism whereby classical visual cycle activity 
can be tuned to match the high visual chromophore demands of 
cone photoreceptors (Moiseyev et al., 2008).
On the other hand, there are several lines of biochemical and 
electrophysiological evidence to suggest that the neurosensory 
retina possesses alternative visual cycle machinery devoted to 
cone pigment regeneration, indicating that there are RPE65-in-
dependent mechanisms for visual chromophore production 
(Fig. 1; Mata et al., 2002; Muniz et al., 2009; Wang et al., 2009). 
This alternative route of visual chromophore delivery is critically 
dependent on Müller glia (Jones et al., 1989; Das et al., 1992; Mata 
et al., 2002; Wang and Kefalov, 2009, 2011; Saari, 2012), and can-
didate enzymes of the mammalian pathway have recently been 
identified, including the putative isomerase sphingolipid del-
ta(4)-desaturase 1 (DES1; Kaylor et al., 2013). Additional enzymes 
and potentially alternative enzymatic activities involved in 
cis-retinoid formation have also been identified in Müller cells 
of chicken (Muniz et al., 2009) and zebrafish (Takahashi et al., 
2011) retina. More recent work has shown that 11-cis-retinal-
dehyde can also be generated nonenzymatically in situ within 
photoreceptor outer segments through the action of blue light 
on all-trans-retinaldehyde-phosphatidylethanolamine adducts 
(Kaylor et al., 2017). Notably, the emergence of ancestral cone pig-
ments during chordate evolution (Lamb, 2013) is thought to have 
preceded the development of RPE65 and the classical visual cycle 
in vertebrates by several million years (Albalat, 2012; Poliakov et 
al., 2012b), indicating the existence of alternative chromophore 
regeneration pathway(s) that could be retained in extant species 
(Kusakabe et al., 2001). However, no direct genetic evidence yet 
demonstrates the involvement of alternative enzymes in cone 
pigment regeneration, and the existence of an RPE65-indepen-
dent, cone-specific regeneration pathway remains controversial.
The rapid degeneration of cone photoreceptors that occurs in 
response to genetic perturbations of the RPE65 gene complicates 
the analysis of cone photoreceptor dependence on this enzyme 
(Cideciyan, 2010). Use of pharmacological agents to acutely block 
RPE65 function without direct effects on cone photoreceptor 
health offers an experimental strategy to overcome this limita-
tion. Analysis of putative RPE65 isomerization intermediates has 
helped to identify retinylamine (Ret-NH2) as a transition state 
analogue inhibitor of RPE65 (Golczak et al., 2005b). Subsequent 
studies led to the identification of a related but more potent 
inhibitor, emixustat (Bavik et al., 2015), which was developed as a 
visual cycle modulator for the treatment of dry, age-related mac-
ular degeneration (Kubota et al., 2012). The structure of this mol-
ecule in complex with RPE65 has provided a clear understanding 
of its mode of action as a competitive inhibitor of retinyl ester 
binding (Kiser et al., 2015). Likewise, the retinoic acid derivative 
fenretinide has been identified as a competitive inhibitor of DES1 
activity (Rahmaniyan et al., 2011; Kaylor et al., 2013), although 
this molecule is known to interact with other molecular targets 
(Berni and Formelli, 1992; Dew et al., 1993; Poliakov et al., 2012a). 
Pharmacological approaches have previously been used to study 
isomerase activity in vitro (Gollapalli and Rando, 2003; Golczak 
Figure 1. Mechanisms for visual chromophore production in the retina 
relevant to cone pigment regeneration. Cone-mediated vision is initiated by 
photoisomerization of 11-cis-retinaldehyde bound to cone visual pigments, a 
process that leads to pigment activation and initiation of phototransduction. 
Photoisomerization leads to the release of all-trans-retinaldehyde from the 
visual pigment, which must be regenerated to allow for sustained visual func-
tion. Two enzymatic systems are thought to contribute to 11-cis-retinalde-
hyde production for the regeneration of cone pigments. The classical RPE65- 
dependent visual cycle pathway involves enzymes and retinoid-binding pro-
teins located in photoreceptor outer segments and the RPE. This pathway 
is also critically involved in rod pigment regeneration. The RPE can store 
11-cis-retinoids either in the form of 11-cis-retinaldehyde or 11-cis-retinol 
complexed with cellular retinaldehyde-binding proteins or, in some species, 
as 11-cis-retinyl esters. A second cone-specific enzymatic pathway, which 
is believed to be RPE65 independent and mechanistically distinct from the 
classical visual cycle, may involve enzymes and binding protein components 
located in cones and Müller cells. This pathway could generate the 11-cis-ret-
inoids that are present in Müller glia, but such compounds could also orig-
inate in the RPE and be transferred through the retina to the Müller cells. 
Müller cells can store 11-cis-retinoids by the same mechanisms as used by 
RPE, but the extent of 11-cis-retinyl ester formation is species dependent, 
typically being higher in diurnal animals. Selective regeneration of cone visual 
pigments relies on the unique ability of cones to use 11-cis-retinol delivered 
by Müller cells to form the necessary visual chromophore 11-cis-retinalde-
hyde. 11-cis-retinaldehyde also can be generated in situ in a light-dependent 
fashion via photoisomerization of all-trans-retinaldehyde-phosphatidyleth-
anolamine Schiff base adducts. In this figure, solid lines indicate established 
pathways, whereas dashed lines indicate processes that are either hypotheti-
cal or not yet fully characterized. 11cRAL, 11-cis-retinaldehyde; 11cROL, 11-cis- 
retinol; atRAL, all-trans-retinaldehyde; atRE, all-trans-retinyl ester; atROL, 
all-trans-retinol; hν, a photon; PE, phosphatidylethanolamine.
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et al., 2005b, 2008; Muniz et al., 2009; Poliakov et al., 2011) as 
well as in mice (Golczak et al., 2005b; Mandal et al., 2011) and 
zebrafish (Schonthaler et al., 2007; Babino et al., 2015). How-
ever, the selectivity and potency of agents used in these studies 
were, in many cases, either unknown or not ideal. Emixustat and 
related derivatives such as MB-001 (Kiser et al., 2015), however, 
have well-validated modes of RPE65 inhibition with good in vivo 
activity and are therefore important new tools for studying the 
role of RPE65 in rod and cone visual pigment regeneration.
In this study, we determined the inhibitory specificity of 
Ret-NH2/emixustat-family compounds toward RPE65 and then 
investigated how selective and acute suppression of the RPE-
based visual cycle affects cone function and dark adaptation in 
mice and ground squirrels possessing rod- and cone-dominant 
retinas, respectively. We also investigated the effects of fenre-
tinide treatment on cone function. These experiments allowed 
us to determine the relative importance of the RPE65-dependent 
visual cycle in acutely supplying visual chromophore to cones 




Ret-NH2 (Golczak et al., 2005b), QEA-B-001-NH2 (Zhang et al., 
2015b), emixustat, and MB-001 (Kiser et al., 2015) were synthe-
sized according to previously described procedures. Fenretinide 
was purchased from Sigma-Aldrich or Toronto Research Chem-
icals, and the chemical identity was confirmed by optical spec-
troscopy. Standard laboratory chemicals were purchased from 
Sigma-Aldrich or USB and were of the highest available purity.
Retinoid isomerase activity assays
RPE65 retinoid isomerase activity was assayed as previously 
described (Stecher et al., 1999; McBee et al., 2000). Assays with 
ground squirrel RPE samples were performed using whole cell 
lysates as opposed to isolated microsomes because of the limited 
amount of material available.
RPE65 immunoblotting
Protein samples containing RPE65 were separated by SDS-PAGE 
on a 10% Tris-glycine polyacrylamide gel and then transferred 
to a 0.45-µm pore size polyvinylidene difluoride membrane. 
Phosphate-buffered saline containing 0.05% Tween 20 (Thermo 
Fisher Scientific) and 5% nonfat powdered milk was used as the 
blocking and incubation buffer. An in-house–generated RPE65 
antibody (Golczak et al., 2010) at a 1:1,000 dilution was used for 
the primary incubation, which was subsequently detected with 
a horseradish peroxidase–conjugated anti–mouse IgG secondary 
antibody (Promega) and chemiluminescence reagent (Thermo 
Fisher Scientific).
Animal handling
Mice were housed in the animal facilities at the Case Western 
Reserve University School of Medicine, where they received a 
standard chow diet (LabDiet 5053) and were maintained under 
a 12-h light (∼300 lux) and 12-h dark cycle; at the Washington 
University School of Medicine, where they received a standard 
chow diet (LabDiet 5053) and were maintained under a 12-h 
light (∼20 lux) and 12-h dark cycle; or at the Cole Eye Institute 
animal facility, where they received LabDiet 2918 and were 
maintained under a 14-h light (∼100 lux) and 10-h dark cycle. 
13-lined ground squirrels (Ictidomys tridecemlineatus) were 
housed individually at the National Institutes of Health Veteri-
nary Research and Resources Section, where they received a Cat 
Chow Complete (Nestlé Purina) diet and were kept in a 12-h light 
and 12-h dark cycle.
All animal procedures and experiments were approved by the 
Institutional Animal Care and Use Committees of Case Western 
Reserve University, the National Eye Institute, Washington Uni-
versity, or the Cleveland Clinic; conformed to the recommenda-
tions of the American Veterinary Medical Association Panel on 
Euthanasia; and were conducted in accordance with the Associa-
tion for Research in Vision and Ophthalmology Statement for the 
Use of Animals in Ophthalmic and Visual Research.
Liver microsome isolation
Liver microsomes from Lrat−/− mice on a C57BL/6J genetic back-
ground were used as the enzyme source for the DES1 activity 
assays to eliminate potential LRAT-dependent acylation of test 
compounds (Batten et al., 2004; Golczak et al., 2005a; Zhang et 
al., 2015b). Four 8-wk-old mice were euthanized by CO2 asphyxi-
ation and cervical dislocation, and their livers (4.6 g in total) were 
removed by dissection, washed in ice-cold phosphate-buffered 
saline, flash frozen in liquid nitrogen, and stored at −80°C. Liver 
microsomes were isolated by differential centrifugation as pre-
viously described (Schulze et al., 2000). The microsomes then 
were suspended in 100 mM sodium phosphate, pH 7.4, to a final 
protein concentration of 15 mg/ml as determined by the Bradford 
assay with BSA used as the standard. Microsome preparations 
were flash frozen in liquid nitrogen and stored at −80°C.
DES1 activity assays
Based on the finding that the retinol isomerase activity of DES1 
is competitive with its dihydroceramide desaturase activity 
(Kaylor et al., 2013), the influence of RPE65 inhibitors on DES1 
catalytic function was assessed by measuring DES1 dihydrocera-
mide activity in the presence of these compounds with a radioac-
tivity-based assay in which 3H is released from 4,5-3H-dihydro-
ceramide in the form of tritiated water as a result of DES1 catalytic 
activity. This assay used mouse liver microsomes isolated as 
described in the preceding section along with a substrate, N-oc-
tanoyl-dihydroceramide (C8-dihydroceramide), which has been 
previously shown to compete with retinol for binding to the DES1 
active site (Fig. S1 A; Schulze et al., 2000; Kaylor et al., 2013). The 
dihydroceramide desaturase activity from this source was linear 
over the assay time course and approximately proportional to the 
enzyme concentration (Fig. S1 B) and also exhibited steady-state 
kinetic parameters similar to those previously reported for rat 
liver microsomes (Fig. S1 C; Rahmaniyan et al., 2011). Reactions 
were performed in 20  mM sodium phosphate, pH 8, contain-
ing 50 mM NaCl, 50 mM sucrose, 2 mM reduced nicotinamide 
adenine dinucleotide (NADH), and 120 µg microsomal protein 
in a total volume of 500  µl. C8-dihydroceramide (Matreya), 
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solubilized in 100  mM sodium phosphate, pH 7.4, containing 
179 mM 3-[(3-cholamidopropyl)dimethylammonio]-1-propane-
sulfonate (CHA PS; Anatrace), was used as a substrate for the 
reaction. 1 µl ethanolic solution of 4,5-3H-C8-dihydroceramide (1 
µCi/µl; American Radiolabeled Chemicals) was added to 22.2 µl of 
solubilization buffer, and the mixture was vortexed for 30 s. 1 µl 
of the diluted radiolabeled substrate (0.043 µCi, ∼150,000 dpm) 
was used per reaction. The final concentration of CHA PS in the 
reaction mixtures was fixed at 1.59 mM. For inhibitor studies, 
the test compounds were delivered into the reaction system in 
DMSO, and the sample was mixed by brief vortexing. The final 
DMSO concentration in the assay system was fixed at 0.2% vol/
vol, a level that did not affect DES1 activity. Reaction mixtures 
were preincubated for 10 min at 37°C, and reactions were then 
initiated by addition of substrate followed by brief vortexing. 
Reactions were performed at 37°C with 550 rpm shaking for 
20 min in 1.5-ml tubes. Reactions performed in the absence of 
NADH or with heat-treated microsomes were used to determine 
the background level of the assay. Reactions were terminated 
with 100 µl of 72% trichloroacetic acid followed by vortexing. 
The resulting precipitates were sedimented by centrifugation 
at 16,100 g for 4 min. Supernatants were removed and added to 
1 ml of 0.4 M Na2HPO4 to partially deacidify the solution. The 
resulting mixtures were then applied to a 500-mg, 3-ml Bond 
Elut C18 column (Agilent) preconditioned with 2 ml of 100% 
MeOH followed by equilibration with 2  ml Millipore water. 
Liquid was drawn through the column with a vacuum mani-
fold operating at ≤5 inches of Hg. 2 ml Millipore water was then 
drawn through the column to capture residual aqueous radio-
activity. The entire flow-through volume was added to 10 ml of 
Ultima Gold XR scintillation cocktail (Perkin-Elmer) and mixed 
by shaking. Scintillation recordings were made with a Beckman 
LS6500 instrument.
In vivo ERG of Gnat1−/− mice
3-mo-old Gnat1−/− mice on a BALB/c background (Leu450 vari-
ant of RPE65) were dark adapted overnight and then anesthe-
tized with an intraperitoneal (IP) injection of a ketamine (100 
mg/kg) and xylazine (20 mg/kg) mixture. Pupils were dilated 
with a drop of 1% atropine sulfate. The mouse body tempera-
ture was maintained at 37°C with a heating pad. ERG responses 
were recorded from both eyes by contact electrodes connected 
to the cornea by a drop of Gonak solution. Full-field ERGs were 
performed with a UTAS BigShot apparatus (LKC Technologies) 
using Ganzfeld-derived test flashes of calibrated green 530-nm 
light-emitting diode (LED) light ranging from 0.24 to 7.45 cd∙s/
m2. Cone b-wave flash sensitivity (Sf) was first calculated in the 
dark as follows:
  S f = R / ( R max ⋅ I ) , 
where R is the cone b-wave dim flash response amplitude, Rmax 
is the maximal response amplitude for that retina obtained with 
the brightest white light stimulus of the Xenon Flash tube (700 
cd∙s/m2), and I is the flash strength. Then, >90% of the M-cone 
pigment was bleached by a 30-s exposure to 520-nm LED light 
focused at the surface of the cornea. The bleaching fraction was 
estimated with the following equation:
  F = 1 −  e −I⋅P⋅t , 
where F is the fraction of bleached pigment, t is the duration of 
the exposure to light (in seconds), I is the bleaching light intensity 
of unattenuated 520-nm LED light (∼1.3 × 108 photons µm−2s−1), 
and P is the photosensitivity of the mouse cone at the wavelength 
of peak absorbance (7.5 × 10−9 µm2), adopted from Nikonov et al. 
(2006). After the bleach, recovery of cone b-wave Sf was followed 
in the dark for up to 1 h. Mice were reanesthetized once (at 20 min 
after bleach) with a smaller dose of ketamine (approximately half 
the initial dose), and a 1:1 mixture of phosphate-buffered saline 
and Gonak solutions was gently applied to the eyes to protect them 
from drying and to maintain electrode contacts.
To test cone function under extended photopic conditions, 
white-background Ganzfeld illumination (300 cd/m2) was 
applied to dark-adapted mice continuously for 30 min, and the 
cone b-wave Sf change was monitored during this period. After 
the exposure, recovery of cone b-wave Sf was monitored in the 
dark for up to 1 h, and anesthesia was reapplied every 30 min.
Ret-NH2 was dissolved before each experiment in DMSO to 
5 µg/µl, and 50 µl of this solution was administered by IP injec-
tion in the dark, followed by a period of 22–26 h of dark adap-
tation before recordings. The other compounds were delivered 
similarly in 50 µl DMSO. Their final concentrations were 4 µg/
µl emixustat, 4 µg/µl MB-001, or 40 µg/µl QEA-B-001-NH2. Con-
trol animals were injected with 50 µl DMSO and processed in the 
same way as drug-treated mice.
Ex vivo ERG recordings from isolated Gnat1−/− mouse retinas
3-mo-old Gnat1−/− mice were dark adapted overnight and sac-
rificed. A whole retina was removed from each mouse eyecup 
under infrared illumination and stored in oxygenated aque-
ous L15 solution (13.6 mg/ml, pH 7.4; Sigma-Aldrich) contain-
ing 0.1% BSA at room temperature. The retina was mounted 
on filter paper with the photoreceptor side up and placed in a 
perfusion chamber between two electrodes connected to a dif-
ferential amplifier. The preparation was perfused with Locke’s 
solution containing 112.5 mM NaCl, 3.6 mM KCl, 2.4 mM MgCl2, 
1.2 mM CaCl2, 10 mM HEP ES, pH 7.4, 20 mM NaHCO3, 3 mM 
sodium succinate, 0.5 mM sodium glutamate, 0.02 mM EDTA, 
and 10 mM glucose. This solution was supplemented with 2 mM 
l-glutamate and 10 µM dl-2-amino-4-phosphonobutyric acid to 
block postsynaptic components of the photoresponse (Sillman 
et al., 1969) and with 20  µM BaCl2 to suppress the slow glial 
PIII component (Nymark et al., 2005). The perfusion solution 
was continuously bubbled with a 95% O2/5% CO2 mixture and 
heated to 36–37°C.
Light stimulation was applied in 20-ms test flashes of cali-
brated 505-nm LED light. The light intensity was controlled by a 
computer in 0.5 log unit steps. To monitor the recovery of cone 
a-wave flash sensitivity (Sf, defined as for the b-wave above) after 
the bleach, >90% of M-cone visual pigment was bleached with a 
3-s exposure to 505-nm light. Photoresponses were amplified by 
a differential amplifier (DP-311; Warner Instruments), low-pass 
filtered at 30 Hz (eight-pole Bessel), digitized at 1 kHz, and stored 
on a computer. Data were analyzed with Clampfit 10.4 (Molecular 
Devices) and Origin 8.5 (OriginLab) software.
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Ret-NH2 and DMSO were administered to each dark-adapted 
mouse by IP injection as described above, followed by a further 
period of 15–17 h of dark adaptation before physiological record-
ings. Fenretinide was dissolved in DMSO and acutely added to the 
isolated, dark-adapted retina, which was flat mounted on filter 
paper with the photoreceptor side up and placed into 2 ml L15 
solution containing 1% BSA (final concentrations of the drug were 
100 µM or 650 µM, and that of DMSO was 1.3%). After preincuba-
tion for 1 h at room temperature, the retina was exposed to moder-
ate 520-nm light for 2 min to bleach the bulk of cone pigment, and 
trans-retinal ERG recordings were performed after another hour 
in darkness. Control experiments were performed in an identical 
way but with DMSO only. Some retinas were treated with fenre-
tinide or DMSO for 1 h but not bleached before recordings.
In vivo ERGs in wild-type mice
C57BL/6J mice aged 2 or 7 mo were anesthetized with ketamine 
(80 mg/kg) and xylazine (16 mg/kg). Mydriatic eye drops (1% 
tropicamide–2.5% phenylephrine–1% cyclopentolate or 1% tropi-
camide alone) were used to dilate the pupil. ERGs were obtained 
using a stainless steel active electrode that contacted the corneal 
surface through a layer of 1% carboxymethylcellulose or normal 
saline. Needle electrodes placed in the cheek and tail provided 
reference and ground leads, respectively. Strobe stimuli were 
presented in a Ganzfeld (LKC Technologies), either in darkness or 
under photopic conditions where stimulus flashes were superim-
posed on a steady adapting field (20 cd/m2) after at least 5 min of 
light adaptation. Responses were amplified, averaged, and stored 
using an LKC Technologies UTAS E-3000 signal averaging sys-
tem. Under dark-adapted conditions, stimulus strength ranged 
from −3.6 to 2.1 log cd·s/m2. Across this range, the interstimu-
lus interval increased from 4 to 65 s with increasing flash lumi-
nance, whereas the number of averaged consecutive responses 
decreased over the same stimulus range from 20 at the lowest 
flash luminance to a single response at the highest strength stim-
ulus. Under light-adapted conditions, stimulus strength ranged 
from −0.4 to 1.9 log cd·s/m2, and flashes were presented at 2 Hz. 
For each light-adapted stimulus condition, up to 50 consecutive 
responses were averaged.
Baseline light-adapted ERGs were recorded from each mouse. 
Mice were injected IP in the morning with 50 µl of vehicle (10% 
DMSO in normal saline) or MB-001 (160 µg/mouse/day) for three 
successive days and kept under normal cyclic lighting conditions 
(14 h light/10 h dark). Both male and female mice were used. The 
morning after the final injection, mydriatic eye drops were used 
to dilate the pupils. Mice were placed in darkness after one of two 
light exposures. Bleach mice were exposed to a 10-min × 10,000-
lux bleach, whereas no bleach mice were not. After a 6-h dark 
adaptation, mice were anesthetized as described above, and a 
series of dark- and light-adapted ERGs were recorded.
For fenretinide experiments, mice were given either 6 mg fen-
retinide (∼267 mg/kg) or vehicle (50% DMSO and 25% ethanol 
in water) by IP injection for three consecutive days. On the third 
day, 1 h after the final dose, the animals were given mydriatic 
eye drops and then were subjected to a 10-min × 10,000-lux pho-
tobleach. The animals were then allowed to dark adapt for 6 h 
before ERG recordings.
To test the impact of MB-001 treatment on fully dark-adapted 
rod responses without a prior photobleach or other light expo-
sure during the period of drug exposure, MB-001 at a dose of 8 
mg/kg was given to 2-mo-old C57BL/6J mice for two consecutive 
days via IP injection. These mice were housed in darkness for 
24 h before drug administration, and the drug was administered 
under dim red light. After the recording of dark-adapted ERGs 
2 h after the second dose using the protocol described above, the 
animals were subjected to a 10-min × 10,000-lux photobleach 
under anesthesia and then allowed to dark adapt for 22 h. After 
this period, scotopic ERGs were remeasured. For MB-001–treated 
mice, dark-adapted ERGs were also measured again after a 2-wk 
drug washout period.
In vivo ERGs in squirrels
Healthy 13-lined ground squirrels (I. tridicemlineatus, 3–6 
mo old, during the summer season) of both sexes were used 
for ERG recordings. Before ERG recording, the animals were 
anesthetized using 3–4% isofluorane suspended in pure oxy-
gen, and their pupils were dilated using ophthalmic 1% tropi-
camide and 2.5% phenylephrine, with 0.5% proparacaine used 
as a local anesthetic. Body temperature was maintained at 37°C 
with a warm bed, and the heart rate was monitored contin-
uously. ERG signals were measured differentially using gold 
electrodes coated with hydroxypropyl-methylcellulose that 
were pressed into the cornea of both eyes, and a subdermal 
scalp tungsten needle was the reference electrode. The Espion 
Color-Dome system (Diagnosys LLC) was used for data acquisi-
tion and stimulation. The data were sampled at a rate of 1,000 
Hz and low-pass filtered at 200 Hz. The built-in xenon lamp 
was used for stimulation with flashes of  <2 ms in duration 
and spanning 0.1–4,000 cd·s/m2 in intensity. In preliminary 
experiments with normal squirrels, exposure to a bright and 
broadband LED source (Migthex White LED 5 500K at maxi-
mal intensity, focused on one eye at a distance of 10 cm and for 
a 10-min period) successfully suppressed the response (>90%) 
to a midintensity flash (100 cd·s/m2), with near-complete 
recovery of responses in the following 10 min. This treatment 
was adopted as our bleaching protocol. The recovery of ERG 
sensitivity was monitored after the photobleach by delivering 
midsaturating flashes (100 cd·s/m2 except for one high-dose 
MB-001–treated animal in which 300 cd·s/m2 was used) every 
1.5 s, with periodic gaps required to save data and restart the 
stimulation protocol.
After recording baseline ERGs, the animals were injected with 
MB-001 or vehicle using two different treatment protocols. In 
the first, MB-001 at a dose of 8 mg/kg/day or the vehicle solu-
tion (10% vol/vol DMSO in 0.9% saline) was injected IP for three 
consecutive days in four squirrels. During this time, the animals 
were kept under normal cyclical lighting conditions. After the 3 
d of treatment, ERGs were recorded again. After a 6-wk wash-
out period, the treatments were crossed over in the same four 
subjects to perform a paired analysis, repeating the same pro-
cedures but opposite treatments. After the last recording, the 
squirrels were sacrificed by decapitation after deep anesthesia 
with isofluorane, and their eyes were collected and immediately 
immersed into liquid nitrogen. The eyes were stored at −80°C 
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until quantification of MB-001 levels. In the second treatment 
protocol, either MB-001 at doses of 8 mg/kg/day or 80 mg/kg/
day or vehicle (50% vol/vol DMSO and 25% vol/vol EtOH in water) 
was injected IP for three consecutive days. A fenretinide treat-
ment group (166 mg/kg/day delivered IP in the same vehicle) was 
also included in the second protocol. During this time, the ani-
mals were kept under normal cyclical lighting conditions. ERGs 
were recorded on the third day of treatment, 2 h after the final 
injection. After the last recording, the squirrels were sacrificed 
by decapitation after deep anesthesia with isofluorane. Their 
eyes were enucleated, and after removal of the cornea, lens, and 
vitreous and partial removal of the retina, the RPE was collected 
for RPE65 activity assays.
ERG data were analyzed in MAT LAB (MathWorks) with cus-
tom scripts and colormaps designed and made publicly available 
by Matteo Niccoli (Niccoli, 2018). Three to five trials per flash 
intensity were averaged after baseline subtraction. The aver-
aged traces were used to identify the amplitude of the a-wave 
as the maximal downward deflection in the first 30 ms after 
stimulation and the amplitude of the b-wave as the maximal 
upward deflection up to 100 ms after stimulation. To assess the 
effect of pharmacological treatment, the difference before and 
10 min after the bleaching protocol (expressed as a percentage) 
was calculated for both the a- and b-wave amplitudes at every 
light intensity used for stimulation. This difference was calcu-
lated only for flash intensities >10 cd·s/m2. Below this intensity, 
ERG responses were small and noisy. Recovery data spanning 
the full 600-s time window were fit with the exponential rise to 
plateau equation
  F(t) = a + c ×  [ 1 − exp (− t / τ) ] 
using the lsqcurvefit routines in MAT LAB, with a (baseline shift 
variable), c (fractional recovery at t = +∞), and τ (the recovery 
time constant) variables treated as free parameters. Although 
cone sensitivity recovery obeys a rate-limited kinetic model 
(Mahroo and Lamb, 2004), reasonable fits were obtained here 
with the simpler exponential function. The recovery fraction 
was calculated as the b-wave amplitude 500–600 s after bleach 
divided by the prebleach b-wave amplitude.
Quantification of MB-001 in squirrel and mouse eyes
Eyes from ground squirrels or C57BL6/J mice that had received 
three consecutive days of IP MB-001 treatment (8 mg/kg/day) 
were homogenized in 3 ml of 10 mM sodium phosphate buffer, 
pH 7.4, containing 50% vol/vol methanol and hydroxylamine 
(50  mM). After adding 4  ml brine, the resulting mixture was 
extracted twice with 4 ml ethyl acetate. The combined extracts 
were dried in vacuo and reconstituted in 400  µl ethanol con-
taining 2 nmol emixustat as the internal standard. This solution 
(100 µl) was analyzed by liquid chromatography–electrospray 
ionization tandem mass spectrometry with a Finnigan LXQ mass 
spectrometer (Thermo Fisher Scientific) and a 4.6 × 150–mm 
ZOR BAX Eclipse XDB-C18 column (Agilent) with a gradient of 
acetonitrile in water (0–100% in 20 min) as the eluent at a flow 
rate of 0.5 ml/min. Amounts of MB-001 were quantified based 
on a standard curve representing the relationship between the 
amount of MB-001 and the ratio of the corresponding selected 
reaction monitoring peak areas of MB-001 (m/z 304.2→257.2) to 
emixustat (m/z 264.2→246.2).
Online supplemental material
Fig. S1 shows validation of the DES1 activity assay. Fig. S2 shows 
the effects of RPE65 inhibitors on DES1 enzymatic function. Fig. 
S3 shows the effects of MB-001 on dark-adapted mouse ERG 
responses. Fig. S4 shows the impact of MB-001 treatment on ERG 
responses in ground squirrels after the multiday dosing sched-
ule used in wild-type mice. Fig. S5 shows the standard curve 
for MB-001 quantification. Fig. S6 shows the quantification of 
MB-001 levels in mouse and squirrel eyes. Table S1 summarizes 
the kinetic data presented in Fig. S2.
Results
Emixustat derivatives selectively inhibit RPE65 over DES1
Although the inhibitory activity of emixustat toward RPE65 has 
been studied extensively, its selectivity for this enzyme has not 
been established. Specifically, it is unknown whether emixustat 
or its derivatives also inhibit DES1. We therefore determined the 
influence of these RPE65 inhibitors on DES1 catalytic function 
(Fig. 2 A). We observed that MB-001 and emixustat had little or 
no inhibitory activity toward DES1, even at a concentration of 
100 µM (Fig. 2 B), whereas RPE65 activity was drastically reduced 
by these compounds at a concentration of 10 µM (Fig. 2 C); the 
latter finding is consistent with prior data (Kiser et al., 2015; 
Zhang et al., 2015b). Conversely, the known DES1 inhibitor fen-
retinide (Rahmaniyan et al., 2011) strongly suppressed DES1 
dihydroceramide desaturase activity at a concentration of 10 µM 
(Fig. 2 B) but had minimal effects on RPE65 retinoid isomerase 
activity (Fig. 2 C), confirming previous results (Golczak et al., 
2008). Inhibition by Ret-NH2 was intermediate between these 
two extremes, with ∼50% inhibition of DES1 activity achieved at 
a concentration of 100 µM and slightly less RPE65 inhibition at 
a concentration of 10 µM compared with the emixustat deriva-
tives. The Ki values and modes of inhibition of the RPE65 inhib-
itors toward DES1 activity are summarized in Fig. S2 and Table 
S1. These data establish the utility of emixustat derivatives in 
selectively blocking RPE65-driven retinoid isomerization.
Impact of retinoid isomerase inhibition on cone dark 
adaptation after a brief step bleach
Having established the selectivity of Ret-NH2, emixustat, and 
MB-001 toward RPE65, we next used ERG to investigate how 
their inhibition of the classical RPE visual cycle affects cone 
photoreceptor function. To facilitate isolation of the cone com-
ponent of the ERG response, these experiments were performed 
with mice lacking the α subunit of rod transducin (Gnat1−/−), 
an essential component of the rod phototransduction cascade. 
Deletion of the transducin α subunit blocks rod responses while 
preserving the structure of the retina as well as cone signaling 
(Calvert et al., 2000).
First, we recorded cone b-wave responses from dark-adapted 
Gnat1−/− mice by in vivo ERGs and estimated their photopic 
b-wave flash sensitivity. Treatment of mice with Ret-NH2 had no 
detrimental effect on the function of cones under dark-adapted 
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conditions, as their sensitivity was not suppressed compared 
with that of DMSO-treated controls (Fig. 3 A). Mice then were 
exposed to brief bright light to bleach >90% of their visual pig-
ment. This resulted in a substantial initial desensitization, fol-
lowed by progressive recovery as the cone visual pigments were 
gradually regenerated. Comparison of the time course of cone-
driven b-wave sensitivity recovery revealed that treatment with 
Ret-NH2 suppressed the late phase of cone dark adaptation rela-
tive to vehicle-treated controls. As a result, the final level of cone 
sensitivity 1 h after the bleach was twofold lower in Ret-NH2–
treated mice than in control mice treated with DMSO (Fig. 3 A). 
This result is consistent with the view that, in mice, the late phase 
of cone dark adaptation after a brief step bleach is mediated by 
the classical RPE visual cycle. In contrast, the early phase of cone 
dark adaptation over the first ∼10 min after the bleach was not 
suppressed by treatment with Ret-NH2. Using data from salaman-
der cones (Kefalov et al., 2005), the recovery of cone sensitivity 
at this time point suggests that >50% of the cone visual pigment 
was regenerated despite inhibition of the RPE visual cycle. This 
finding suggests that after a step bleach, the early component of 
mouse cone dark adaptation is independent of RPE65 (i.e., not 
acutely dependent on continuous RPE65 activity).
The initial component of cone dark adaptation in vivo is 
thought to be driven by the intraretinal visual cycle (Kolesnikov 
et al., 2011). To confirm that this part of cone recovery is indepen-
dent of the RPE, we examined the dark adaptation of cones in iso-
lated retina after a step bleach. Under these conditions, the RPE is 
removed and the RPE visual cycle does not contribute to recovery, 
leaving the intraretinal visual cycle as the sole source of chromo-
phore driving cone pigment regeneration. Comparison of retinas 
from vehicle- and Ret-NH2–treated mice revealed identical time 
courses of cone dark adaptation (Fig. 3 B). Thus, Ret-NH2 did 
not affect cone dark adaptation in the isolated retina, consistent 
with our finding that Ret-NH2 does not effectively inhibit DES1. 
Rather, these findings indicate that the early rapid phase of cone 
dark adaptation after a step bleach is independent of RPE65 and 
is instead driven by the intraretinal visual cycle. Using the same 
ex vivo system, we also investigated the impact of DES1 inhi-
bition by fenretinide on cone dark adaptation. Compared with 
vehicle-treated retinas, those exposed to 100  µM fenretinide 
exhibited a modest decrease in photosensitivity (Fig. 4). Photo-
sensitivity was further decreased only slightly at a concentration 
of 650 µM, indicating that the effect had plateaued. These results 
further support a physiological role for DES1 in cone recovery 
mediated by the intraretinal visual cycle.
Emixustat and MB-001 exhibited even greater inhibitory 
potency and selectivity toward RPE65 compared with Ret-NH2 
(Fig.  2). Like Ret-NH2, both emixustat (Fig.  5  A) and MB-001 
(Fig. 5 B) inhibited the late phase of cone dark adaptation, but 
neither compound slowed early recovery after the photobleach. 
Ret-NH2, emixustat, and MB-001 contain primary amine func-
tional groups that are capable of directly reacting with retinal-
dehyde to form Schiff base adducts. To rule out the possibility 
of retinaldehyde sequestration giving rise to the late-phase 
dark adaptation effects, we tested QEA-B-001-NH2, a compound 
that functions as a retinaldehyde sequestrant without inhib-
iting RPE65 (Zhang et al., 2015a). No suppression of cone dark 
adaptation in mice treated with QEA-B-001-NH2 was observed 
(Fig. 5 C). These observations demonstrate that the early com-
ponent of mouse cone dark adaptation in the intact eye after a 
Figure 2. Selectivity of RPE65 and DES1 inhibitors. (A) Chemical structures of RPE65 and DES1 inhibitors used in this study. (B) Inhibitory effects of reti-
noids, emixustat, and emixustat derivatives on DES1 activity in liver microsomes from 8-wk-old Lrat−/− mice. Fenretinide, a known DES1 inhibitor, at a concen-
tration of 10 µM suppressed DES1 activity nearly as well as heat treatment or omission of the required NADH cofactor. RPE65 inhibitors, in contrast, had less 
pronounced effects on activity. Assays shown here were performed at a fixed substrate concentration of 0.5 µM. Activity levels are normalized to that of the 
DMSO-only control samples. DMSO, at the concentration used in these assays (0.2% vol/vol), did not affect DES1 activity. (C) Inhibitory effects of retinoids, 
emixustat, and emixustat derivatives on 11-cis-retinol production in RPE microsomes. Compounds at final concentrations of 10 µM or 100 µM were incubated 
with RPE microsomes and 20 µM all-trans-retinol. Activities are normalized to DMSO-only treated samples. The bar graphs show mean values, and error bars 
represent SDs from at least three separate experiments.
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brief step bleach is driven by an RPE65-independent mecha-
nism, whereas RPE65 contributes substantially to the late-phase 
recovery process.
Impact of RPE65 inhibition on cone function during extended 
photopic conditions
In their normal daily function, cones are rarely exposed to such 
brief, intense light exposures as the ones used in the preceding 
experiments. Thus, to test the efficiency of chromophore supply 
to cones under more physiological conditions, we exposed mice 
to 30 min of bright background light followed by a period of dark 
adaptation. Inefficient pigment regeneration in this case should 
result in gradual depletion of cone visual pigment and progres-
sive cone desensitization during light exposure (Kolesnikov et 
al., 2015), as well as a delay in the subsequent cone dark adapta-
tion upon extinction of the background light. In DMSO-treated 
Gnat1−/− mice, this protocol resulted in an ∼100-fold cone desen-
sitization caused by light adaptation in bright background 
(Fig. 6 A, black circles). However, cone sensitivity remained sta-
ble for the duration of the background light, indicating sustained 
pigment regeneration. Upon the return to darkness, cone sensi-
tivity recovered gradually over the next 30 min as cone pigment 
regenerated. Notably, treatment with emixustat did not compro-
mise the ability of cones to maintain their sensitivity during the 
30-min exposure to bright light (Fig. 6 A). Thus, cones were able 
to sustain robust function in bright light despite blockade of the 
RPE visual cycle by emixustat. All phases of cone dark adaptation 
upon return to darkness were delayed in emixustat-treated mice 
compared with vehicle-treated controls, suggesting an import-
ant role of the RPE visual cycle for cone pigment regeneration 
in these conditions. Similar experiments with MB-001 yielded 
comparable results; however, we observed a subtle and gradual 
desensitization of the cones during the 30 min of photopic expo-
sure (Fig. 6 B). Finally, we also tested how cone function under 
photopic conditions is affected by the all-trans-retinaldehyde 
sequestrant QEA-B-001-NH2. Consistent with the inability of 
this compound to inhibit cone dark adaptation after a step bleach 
(Fig. 5 C), QEA-B-001-NH2 also had no effect on cone function 
during prolonged light exposure (Fig. 6 C). The subsequent dark 
adaptation of cones also was comparable in QEA-B-001-NH2– and 
DMSO-treated mice.
Effects of retinoid isomerase inhibitor treatment on wild-type 
mouse photoreceptor responses
As a prelude to the evaluation of multiday RPE65 inhibitor 
treatment on cone function in the cone-dominant ground squir-
rel, we tested RPE65 inhibitor treatment on ERG responses in 
wild-type C57BL/6J mice. For these studies, we used MB-001 
because of its strongly selective inhibitory activity toward RPE65 
(Fig. 2 and Table S1).
We recorded a series of dark-adapted (Fig.  7) and light-
adapted (Fig. 8) ERGs from mice treated with vehicle and then 
exposed to a bleach, or from mice treated with MB-001 with or 
without a bleach exposure. In vehicle-treated mice, the dark-
adapted ERG was composed of two major components: a negative 
polarity a-wave followed by a positive polarity b-wave (Fig. 7 A).
The a-wave reflects the light-induced closure of ion channels 
along the rod outer segments, and the b-wave reflects the mass 
response of depolarizing bipolar cells (Abd-El-Barr et al., 2009). 
Rod recovery after a strong photobleach is an established surro-
gate for the ability of RPE65 to synthesize 11-cis-retinol, as the 
rate of rhodopsin regeneration after a full bleach is dependent 
on the expression level and activity of RPE65 (Wenzel et al., 2001; 
Lyubarsky et al., 2005). Compared with ERG responses obtained 
from vehicle-treated mice, which were comparable to prebleach 
responses, the ERG a- and b-wave amplitudes were markedly 
reduced in mice given MB-001 and subjected to a photobleach 
(Fig. 7, A–C). Although clear signals were seen in these animals, 
the responses were reduced in amplitude, and their waveforms 
closely resembled those obtained in Gnat1−/− mice, which lack 
rod-mediated function (Calvert et al., 2000; Wu et al., 2004). The 
Figure 3. Effect of Ret-NH2 on mouse cone dark adaptation. (A and B) 
Cone b-wave ERG responses were recorded in vivo (A), and cone a-wave ERG 
responses were recorded ex vivo (B). Sensitivity in each case was estimated as 
the ratio of the dim flash response and the corresponding flash intensity and 
further normalized to the maximal ERG response amplitude. Rod transducin 
α-deficient mice (Gnat1−/−) were used to isolate the cone-specific component 
of the light responses. Mice (3 mo old) were dark adapted overnight, injected 
with 50 µl DMSO or Ret-NH2 dissolved in DMSO to 5 µg/µl, and then kept in 
darkness for 22–26 h. After determining the sensitivity in the dark-adapted 
state, we exposed the eyes or isolated retinas for 30 s to bright 520-nm light 
estimated to bleach >90% of their visual pigment. Episodic dim flash stimu-
lation was then used to follow the recovery of cone b-wave sensitivity in vivo 
(A) in mice treated with DMSO (n = 16) or with Ret-NH2 (n = 10). Ret-NH2 did 
not affect the early phase of cone dark adaptation driven by the intraretinal 
visual cycle but blocked its late phase, driven by the RPE visual cycle. Recov-
ery of cone a-wave sensitivity ex vivo (B) was measured in isolated retinas 
from mice treated with DMSO (n = 7) or with Ret-NH2 (n = 6). Ret-NH2 did 
not affect the dark adaptation of cones in isolated retina. Data are presented 
as means ± SEM.
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overall amplitudes of the dark-adapted ERG responses of mice 
administered MB-001 but not exposed to the bleach were inter-
mediate between vehicle- and MB-001–treated mice that under-
went the bleach, with rod contributions to the waveforms clearly 
evident (Fig. 7, A–C). These results indicate that administration 
of MB-001 to mice maintained under standard vivarium lighting 
was sufficient to impact rod-mediated function, likely because 
of the accumulation of apo-opsin (Lyubarsky et al., 2004) and 
consequent constitutive signaling that desensitizes the pho-
totransduction pathway in these cells (Cornwall and Fain, 1994; 
Jäger et al., 1996). To exclude the potential effects of MB-001 on 
the ERG that are unrelated to visual cycle suppression, we admin-
istered MB-001 or vehicle to fully dark-adapted mice for two con-
secutive days and 2 h after the last dose measured scotopic ERG 
responses. As shown in Fig. S3, we observed comparable scotopic 
ERG responses between MB-001– and vehicle-treated mice under 
Figure 4. Effect of fenretinide on cone dark adaptation in isolated retina. (A–E) Representative families of ex vivo cone ERG responses from Gnat1−/− 
mouse retinas under specified conditions. (A and C) Test flashes of 505-nm light with intensities of 235, 705, 2.4 × 103, 7.0 × 103, 1.7 × 104, 5.7 × 104, 2.0 × 105, 
and 6.0 × 105 photons/µm2 were delivered at time 0. (B, D, and E) Test flashes of 505-nm light with intensities of 2.4 × 103, 7.0 × 103, 1.7 × 104, 5.7 × 104, 2.0 
× 105, 6.0 × 105, 2.0 × 106, and 5.7 × 106 photons/µm2 were delivered at time 0. In all panels, responses to 1.7 × 104 photons/µm2 light are shown in red for 
comparison of cone sensitivity recovery after a bleach. (F) Averaged cone intensity–response functions (mean ± SEM) for dark-adapted conditions treated for 
1 h with 1.3% DMSO (vehicle control, open circles; n = 6) or with 650 µM fenretinide (open red circles; n = 6) and 1 h after a bleach of retinas preincubated for 
1 h in 1.3% DMSO (vehicle control, closed black circles; n = 11), 100 µM fenretinide (closed blue squares; n = 6), or 650 µM fenretinide (closed red circles; n = 
9). The recovery of cone sensitivity was suppressed by treatment with fenretinide at both 100 µM and 650 µM.
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these conditions, consistent with the lack of prebleach ERG 
effects observed in Gnat1−/− mice (Figs. 5 B and 6 B). After this ini-
tial ERG recording, mice were subjected to a strong photobleach 
(10 min × 10,000 lux) and then allowed to dark adapt for 22 h. 
After dark adaptation, we repeated the scotopic ERG measure-
ments. Whereas vehicle-treated mice had postbleach responses 
comparable to the prebleach values, those from MB-001–treated 
mice were drastically reduced (Fig. S3). After a 2-wk drug wash-
out period, the responses of the MB-001–treated mice returned 
to baseline, demonstrating a lack of long-term residual effects 
caused by either the drug treatment or light exposure. These data 
confirm that ERG effects arising from MB-001 treatment are a 
result of visual cycle suppression rather than off-target effects 
and that this suppression is fully reversible.
Under light-adapted conditions, the mouse ERG response has 
a major positive b-wave that is preceded by a small negative wave 
(Fig. 8 A). The positive b-wave reflects cone-depolarizing bipolar 
cell activity, whereas the negative wave primarily reflects post-
receptor activity of the inner retina (Sharma et al., 2005; Shirato 
Figure 5. Effect of RPE65 inhibitors on mouse cone dark adaptation in 
vivo. The recovery of cone b-wave flash sensitivity after a 90% bleach was 
compared between Gnat1−/− mice treated with DMSO (n = 16) and mice 
treated with RPE65 inhibitors. (A–C) The late, RPE visual cycle–driven phase 
of cone dark adaptation was suppressed by emixustat (A; n = 14) and by 
MB-001 (B; n = 14), but not by QEA-B-001-NH2 (C; n = 10). The early, retina 
visual cycle–driven phase of cone dark adaptation was unaffected in all three 
cases. Data are presented as means ± SEM.
Figure 6. Effect of RPE65 inhibitors on mouse cone function in vivo 
during and after prolonged exposure to background light. Cone b-wave 
sensitivity was monitored during a 30-min exposure of 3-mo-old Gnat1−/− 
mice to bright 300-cd/m2 white background light (gray bars) and then for 35 
min in darkness. (A) Compared with control DMSO treatment (n = 6), cones 
from mice treated with emixustat (n = 10) were equally desensitized by the 
background light but had largely suppressed subsequent dark adaptation. 
(B) In contrast, in mice treated with MB-001 (n = 8), cones gradually desen-
sitized during background adaptation and had suppressed subsequent dark 
adaptation. (C) Treatment with QEA-B-001-NH2 (n = 6) had no effect on the 
function of cones in background light or during the subsequent dark adapta-
tion. Data are presented as means ± SEM.
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et al., 2008). Light-adapted ERGs of mice administered MB-001 
were reduced in both bleached and nonbleached animals in com-
parison to those treated with vehicle (Fig. 8, A and B). This sup-
pression was most prominent with midintensity flashes where 
the ERG response was reduced approximately fivefold and 
threefold in bleached and nonbleached animals, respectively, 
and gradually equalized with higher flash stimuli. These results 
indicate that RPE65 plays a role in restoring cone photoreceptor 
activity in wild-type mice during dark adaptation after a bleach, 
as well as during exposure to standard vivarium light levels, con-
sistent with the results obtained from Gnat1−/− mice.
We also investigated the impact of multiday treatment with 
the DES1 inhibitor fenretinide on ERG responses in wild-type 
mice. We administered fenretinide for three consecutive days at 
a dose of 267 mg/kg/day, which is equivalent to a high-dose regi-
men previously evaluated for ocular effects in humans (Marmor 
et al., 2008). On the third day, 1 h after the final injection, we 
subjected the mice to a 10-min × 10,000-lux photobleach and 
then allowed them to dark adapt for 6 h before ERG recordings 
were performed. Based on human clinical data, fenretinide can 
exert profound effects on rod function with little impact on cones 
(Marmor et al., 2008). In wild-type C57BL6/J mice, we found that 
scotopic ERGs were mildly reduced (Fig. 7, D–F), whereas phot-
opic responses were slightly elevated relative to vehicle control 
(Fig. 8, C and D). Thus, high-dose fenretinide does not appear to 
negatively impact the steady-state level of cone pigment regen-
eration to a detectable degree under these conditions.
Effects of multiday RPE65 inhibitor treatment on ground 
squirrel cone ERG responses
Many of the biochemical studies on the intraretinal visual cycle 
have been conducted using retinas from cone-dominant species 
(Mata et al., 2002, 2005; Gollapalli and Rando, 2003; Muniz et 
al., 2009). However, the contribution of the classical visual cycle 
to cone function has not been thoroughly evaluated in these ani-
mals. We tested the effect of RPE65 inhibition on cone-driven 
ERG responses in the ground squirrel, a rodent whose photore-
ceptor population consists almost exclusively of cones (Jacobs 
Figure 7. Impact of MB-001 and fenretinide administration on wild-type mouse scotopic ERG responses. (A) Representative dark-adapted ERGs obtained 
from 7-mo-old C57BL/6J mice treated with vehicle and bleached, treated with MB-001 and bleached, or treated with MB-001 and not bleached. Animals were 
dark adapted for 6 h before ERG recordings. Flash strength is color coded: black, −3.6 log cd·s/m2; blue, −2.4 log cd·s/m2; light purple, −1.2 log cd·s/m2; purple, 
0 log cd·s/m2; red, 1.4 log cd·s/m2. (B and C) Dark-adapted a-wave and b-wave responses for the three treatment groups. Note that MB-001 reduced a- and 
b-wave ERG amplitude recovery both after a bleach and, to a lesser extent, in mice reared under standard vivarium lighting conditions. Data points indicate 
means (±SEM) of five mice per group for the vehicle and bleached, MB-001–treated groups and three mice for the nonbleached, MB-001–treated group. 
(D) Representative dark-adapted ERGs obtained from 2-mo-old C57BL/6J mice administered vehicle and bleached or administered fenretinide and bleached. 
Animals were dark adapted for 6 h before ERG recordings. Flash strength is color coded: black, −3.6 log cd·s/m2; blue, −2.4 log cd·s/m2; light purple, −1.2 log 
cd·s/m2; purple, 0 log cd·s/m2; red, 1.4 log cd·s/m2. (E and F) Scotopic a-wave and b-wave responses for the two treatment groups. Data points indicate means 
(±SEM) of three mice per group. Fenretinide treatment reduced scotopic b-wave amplitudes slightly, whereas a-wave responses were unaffected.
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and Yolton, 1969; Mustafi et al., 2016). MB-001 or vehicle was 
administered to these animals for three consecutive days. After 
pupillary dilation, MB-001– or vehicle-treated squirrels were 
uniocularly exposed to bright light for 10 min, which completely 
suppressed cone responses to a midintensity flash, followed by 
ERG recordings from both eyes. After a 6-wk washout period, the 
treatment and control groups were crossed over and the experi-
ment was repeated. Using this treatment regimen, which caused 
pronounced ERG effects in mice as described above, the a- and 
b-wave ERG amplitudes were essentially unaffected by MB-001 
treatment in the ground squirrels (Fig. S4). Unlike mice, ground 
squirrels do not produce a reliable rod ERG response that could 
be used to definitively assess the degree of RPE65 inhibition by 
MB-001 (Jacobs et al., 1980). Although MB-001 was detected in 
the eyes of ground squirrels (Figs. S5 and S6), given the relatively 
long period of time that elapsed between the final treatment dose 
and the ERG recordings (∼1 d), we considered the possibility that 
MB-001 is more rapidly eliminated in ground squirrels than in 
mice and hence lost its efficacy during this period.
To address this possibility, we repeated the experiment but 
administered the final treatment dose 2 h before ERG record-
ings. We used the original 8 mg/kg dose as well as an 80 mg/kg 
dose to help ensure that an adequate concentration of MB-001 
was present in the RPE at the time of ERG recording. To directly 
measure the degree of RPE65 inhibition in these animals, the 
RPE was collected from squirrel eyes after ERG recordings, and 
RPE65 activity was measured from the cell lysates. As shown 
in Fig. 9, 11-cis-retinol was generated in assays using RPE from 
Figure 8. Impact of MB-001 and fenretinide administration on wild-type mouse cone-driven ERG responses. (A) Representative light-adapted ERGs 
obtained from 7-mo-old C57BL/6J mice administered vehicle and bleached, administered MB-001 and bleached, or administered MB-001 and not bleached. 
These photopic ERGs were recorded immediately after the scotopic recordings shown in Fig. 7 (A–C) and a 5-min light adaptation period under steady 30 cd/m2 
background light, which was maintained during the recordings. Flash strength is color coded: blue, 0 log cd·s/m2; purple, 0.9 log cd·s/m2; red, 1.9 log cd·s/m2. 
(B) Photopic b-wave responses for the three treatment groups. Data points indicate means (±SEM) of five mice per group for the vehicle and MB-001 bleach 
groups and three mice for the MB-001 no-bleach group. Note that MB-001 reduced cone ERG amplitude recovery after a bleach and reduced cone ERG amplitude 
to a lesser extent in mice reared under standard vivarium lighting conditions. (C) Representative light-adapted ERGs obtained from 2-mo-old C57BL/6J mice 
administered vehicle and bleached or administered fenretinide and bleached. These photopic ERGs were recorded immediately after the scotopic recordings 
shown in Fig. 7 (D–F) and a 5-min light adaptation period under steady 30 cd/m2 background light, which was maintained during the recordings. Flash strength 
is color coded: black, −0.8 log cd·s/m2; blue, 0 log cd·s/m2; purple, 0.9 log cd·s/m2; red, 1.9 log cd·s/m2. (D) Photopic b-wave responses for the two treatment 
groups. Data points indicate the means (±SEM) of three mice per group. Note that light-adapted ERG b-wave amplitudes were slightly greater in mice treated 
with fenretinide as compared with those treated with vehicle.
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vehicle-treated animals (Fig. 9 A), and the production was aug-
mented by the addition of all-trans-retinol to the assay mixture, 
as observed for bovine RPE (Fig. 9 D). In contrast, RPE samples 
obtained from squirrels treated with either dose of MB-001 failed 
to generate 11-cis-retinol (Fig. 9, B and C). Immunoblots showed 
a comparable amount of RPE65 in each sample, thus ruling out 
a lack of visual cycle enzymes in the MB-001–treated samples 
underlying the absence of activity (Fig. 9 E). Whereas vehicle 
and 8 mg/kg/day MB-001 treatment were well tolerated by the 
animals, significant (>50%) mortality was observed for animals 
treated with the 80 mg/kg/day dose of MB-001.
We applied two different ERG recording paradigms to these 
animals. First, we subjected the animals to a 10-min photobleach 
that completely suppressed ERG responses and then monitored 
for ERG recovery with midintensity test flashes over the ensuing 
10 min. Second, after the 10-min recovery period, we subjected 
animals to a series of light flashes to assess ERG responses over 
a range of flash stimuli. Compared with the vehicle treatment, 
MB-001 at both doses dramatically prolonged the time to recov-
ery in all animals investigated (Fig. 10 and Table 1). The mean 
time constant for recovery was ∼51 s before treatments and 40 s 
after 3 d of vehicle treatment but was slowed to ∼1,500 s and 
∼294 s in the low and high MB-001 treatment groups. Moreover, 
in two of the four animals treated with MB-001, the fractional 
recovery 10 min after the end of the photobleach was substan-
tially less than the pretreatment value, whereas vehicle-treated 
animals on average matched their pretreatment recovery levels 
(Fig. 10). Despite this marked delay in ERG response recovery, 
animals from all treatment groups had only subtle alterations 
in their ability to respond to subsequent strobe flashes (Fig. 11). 
Compared with pretreatment responses (Fig. 11 A), the effects 
of MB-001 treatment at a dose of 8 mg/kg/day were essentially 
indistinguishable from vehicle alone (Fig. 11, B and C). MB-001 at 
80 mg/kg produced varying responses in the two animals treated 
with this regimen (Fig. 11 D). In one animal, ERG responses were 
comparable to those of vehicle treatment. The other animal 
had a much more pronounced response to the drug treatment, 
with marked effects on pre- and postbleach a-wave and b-wave 
responses. We note that this animal died 3 d after the recordings 
were made. It is likely that the more profound effect observed in 
this animal was a result of toxicity rather than an accentuated 
on-target effect of the drug.
We also tested the effects of fenretinide on the squirrel cone 
ERG response. We administered fenretinide at a dose of 166 mg/
kg, the body surface area–adjusted equivalent dose used in mice, 
daily for three consecutive days and then assessed ERG responses 
using the same experimental protocol described in the preceding 
paragraph. We found that fenretinide treatment slowed the time 
constant of recovery about threefold relative to vehicle (Fig. 10 
and Table 1) but did not impact responsiveness to a subsequently 
delivered strobe flash series (Fig.  11  E). We observed a trend 
toward the extent of recovery being augmented by fenretinide 
Figure 9. Impact of MB-001 treatment on the production of 11-cis-retinol by ground squirrel RPE. (A–D) Examples of high-performance liquid chroma-
tography separation of retinoids obtained from vehicle-treated squirrels (A), squirrels treated with MB-001 at doses of 8 mg/kg/day (B) or 80 mg/kg/day (C), and 
untreated bovine RPE (D). Blue and red traces show separations from assays performed only with added vehicle (dimethylformamide) or with all-trans-retinol 
delivered in dimethylformamide, respectively. Retinoids are labeled as follows: 1, all-trans-retinyl esters; 2, 11-cis-retinol; 3, all-trans-retinol; and 4, 13-cis-reti-
nol. The insets in A and B show absorbance spectra for peaks 2 and 3. (E) Quantification of 11-cis-retinol production by the indicated RPE samples. The different 
vehicle and 8 mg/kg MB-001 samples are biological replicates. Each sample was assayed in duplicate. The results are presented as means, and the error bars 
represent SDs. An RPE65 immunoblot of the samples loaded at the same relative amounts as used in the assay demonstrates that the difference in isomerase 
activity between the vehicle and drug-treated samples is not attributable to large differences in RPE65 levels. Only a single band at ∼65 kD corresponding to 
RPE65 was visualized on the immunoblot; hence, the image was cropped to the area surrounding this band. DMF, dimethylformamide.
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treatment relative to vehicle control (Fig. 10 and Table 1), which 
is consistent with our findings in wild-type mice (Fig. 8, C and D).
Collectively, the experiments in ground squirrels indicate 
that RPE65 is involved in mammalian cone pigment regenera-
tion as deduced from sensitivity recovery measurements after 
an extended photobleach, but the cones can clearly function in 
a relatively normal fashion with RPE65 activity acutely blocked 
by pharmacological means. The same conclusion can be drawn 
for the putative inhibition of DES1 activity by fenretinide, 
although the effects of this compound were milder compared 
with MB-001.
Discussion
The electrophysiological experiments described in this study 
reveal differing effects of three RPE65-selective inhibitors 
(Ret-NH2, emixustat, and MB-001) on cone pigment regenera-
tion and cone photoreceptor dark adaptation.
Figure 10. Recovery of ERG b-wave responses after a photobleach in drug- and vehicle-treated ground squirrels. After baseline ERG recordings, the 
animals were subjected to a 10-min photobleach that completely suppressed b-wave responses. They were subsequently monitored for ERG recovery with 
flashes giving approximately half-maximal responses (100 cd·s/m2, except for the animal whose responses are shown in the lower graph of the 80 mg/kg/day 
MB-001 column, which required 300 cd·s/m2 to elicit midsaturating responses). Data shown as blue circles were obtained at day 1 before drug or vehicle treat-
ment. Data shown as red circles were obtained after three consecutive days of vehicle or drug treatment at the indicated dose. The later ERGs were measured 
∼2 h after the final dose of drug. Each panel shows data from a single animal. MB-001 at either dose greatly delays the recovery of cone sensitivity. Fenretinide 
also delayed, to a smaller degree, cone sensitivity recovery in two of the three treated animals.
Table 1. Rate constants and recoveries derived from curve fitting to the data shown in Fig. 10

















Day 1 Day 3 Day 1 Day 3 Day 1 Day 3 Day 1 Day 3 Day 1 Day 3 Day 1 Day 3 Day 1 Day 3 Day 1 Day 3
s s s s
35.6 44.0 0.7450 0.6400 52.8 2067.7 0.7480 0.4130 47.0 404.6 0.9710 0.5380 44.2 188.9 0.7540 0.9240
32.8 28.0 0.9620 0.7600 32.8 933.1 0.6910 0.6860 14.4 183.5 0.7550 0.6010 107.1 220.4 0.5850 0.6630
77.6 48.2 0.7450 0.8420 48.3 150.9 0.9490 1.2230
48.67 40.07 0.82 0.75 42.80 1500.40 0.72 0.55 30.70 294.05 0.86 0.57 66.53 186.73 0.76 0.94
Recovery fraction indicates the degree of recovery 10 min after the end of the photobleaching period. For each treatment, the individual rows represent 
values calculated from individual animals. The final row shows column averages.
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After brief, intense light exposure, the initial fast recovery 
of cone light sensitivity, which reflects intraretinal visual cycle 
function (Kolesnikov et al., 2011), is largely unaffected in Gnat1−/− 
mice treated with RPE65-selective inhibitors, whereas the second 
phase recovery component that completes dark adaptation and is 
attributable to the classical visual cycle (Kolesnikov et al., 2015) 
is markedly slowed (Fig. 3 A and Fig. 5, A and B). These obser-
vations are consistent with the existence of a rapid RPE65-in-
dependent mechanism of visual chromophore delivery to cone 
photoreceptors.
The cones of mice treated with RPE65 inhibitors also dis-
played sustained light responsiveness during prolonged expo-
sure to moderately intense background illumination, again 
suggesting RPE65-independent chromophore regeneration 
(Fig. 6, A and B). Interestingly, the time required for cone pho-
toreceptor resensitization after the 30-min light exposure 
(Fig. 6) was somewhat slower compared with the situation in 
which bleaching was achieved with a single intense light flash 
(Fig. 5), possibly reflecting a depletion of cis-retinoid sources. 
Resensitization was slowed to a much greater degree in mice 
treated with RPE65 inhibitors, indicating that RPE65 may be 
particularly important in supporting cone function during sus-
tained light exposure.
Consistent with this proposal, cone ERG responses were also 
suppressed in wild-type mice after extended administration of 
MB-001 and a photobleach followed by a dark adaptation period, 
as indicated by the reduced photopic b-wave amplitudes in these 
animals compared with vehicle-treated controls (Fig. 8, A and 
B). We also observed mild suppression of cones and, to a greater 
degree, rod responses without a prior photobleach when the 
mice were reared in normal vivarium light. This likely reflects 
bleaching desensitization caused by the inability of the pho-
toreceptor pigments to regenerate after being bleached by the 
vivarium light.
In the cone-dominant ground squirrel, as in Gnat1−/− mice, 
the time required for flash sensitivity recovery after an extended 
bleach was markedly prolonged in MB-001–treated animals, and 
in some cases the extent of sensitivity recovery was also sup-
pressed (Fig. 10 and Table 1). However, after the recovery period, 
the ground squirrel cone ERG responses to a flash series were 
remarkably well preserved (Fig. 11), indicating the presence of 
robust pigment regeneration mechanism(s) that are not reliant 
on continuous RPE65 activity. In both wild-type mice and ground 
squirrels, we conclusively ruled out residual RPE65 activity as 
being responsible for the cone-mediated responses. In the case of 
mice, this was confirmed by the absence of rod-related ERG sig-
nals after a 6-h postbleach dark adaptation (Fig. 7, A–C). In squir-
rels, RPE65 activity in isolated RPE was abolished by MB-001 
treatment (Fig. 9).
Our finding that cone function is preserved in the setting of 
reduced RPE-based visual cycle function is consistent with data 
obtained from human clinical trials of emixustat treatment. 
Subjects receiving both acute (Kubota et al., 2012) and chronic 
(Kubota et al., 2014) dosing regimens had minimal changes in 
cone ERG flash and flicker responses despite substantial sup-
pression of rod responses because of RPE65 blockade. Although 
overall cone electrical activity was preserved, dyschromatopsia 
was a frequently reported side effect associated with emixustat 
treatment, which has been attributed to perturbations in rod cell 
modulation of cone sensory output (Kubota et al., 2012).
Fenretinide also exerted modulatory effects on ERG 
responses in these animal models. In isolated Gnat1−/− mouse 
retinas, fenretinide reduced the extent of cone sensitivity 
recovery (Fig. 4), although not as much as observed after the 
complete block of the intraretinal visual cycle by ablation of the 
Müller cells (Wang and Kefalov, 2009). We also observed a lag in 
ground squirrel cone sensitivity recovery after a bleach in ani-
mals treated with this drug (Fig. 10 and Table 1). These effects 
of fenretinide appear to be dependent on the time allowed for 
dark recovery, as fenretinide-treated wild-type mice that were 
allowed an extended time for dark adaptation (6 h) had fully 
recovered and perhaps even had elevated cone ERG responses 
(Fig. 8, C and D). We also observed slightly elevated responses 
after bleach recovery in ground squirrels (Fig. 10 and Table 1). 
The reduction of cone sensitivity exerted by fenretinide may 
relate to its ability to inhibit the putative Müller cell retinoid 
isomerase DES1 (Kaylor et al., 2013). Although fenretinide 
exhibits selectivity for DES1 over RPE65 (Fig. 2, B and C), it has 
other documented molecular targets, including LRAT (Dew 
et al., 1993), β-carotene dioxygenase 1 (Poliakov et al., 2012a), 
and retinol-binding protein 4 (Berni and Formelli, 1992), all 
of which are known to contribute directly or indirectly to 
visual cycle function. Moreover, retinoic acid, a metabolite of 
fenretinide, can inhibit retinol dehydrogenase enzymes (Law 
and Rando, 1989), potentially including those relevant to the 
cone-specific visual cycle (Sato and Kefalov, 2016). Therefore, 
we cannot rule out that the ERG alterations are caused by fen-
retinide’s effects on enzymes other than DES1. The relatively 
Figure 11. Impact of MB-001 and fenretinide treatment on ground squirrel ERG responses to a range of flash intensities. (A) Ground squirrel ERG 
responses to a flash series were measured on day 1 before any drug or vehicle treatment both before and after a 10-min photobleach. (B–E) The responses 
were measured again in the same fashion 3 d later after daily administration of vehicle, MB-001 at 8 mg/kg/day, MB-001 at 80 mg/kg/day, and fenretinide 
at 166 mg/kg/day. The final dose of drug was administered ∼2 h before the ERG recordings. The left graphs show ERG traces for each type of treatment. The 
arrows indicate the time of flash onset. The middle panels show a-wave responses to each flash, and the right panels show the corresponding graphs for b-wave 
responses. The luminance-response plots of A show averaged data for all animals studied (n = 10). The luminance-response plots for B–E show the posttreat-
ment responses for the individual animals studied (red and orange circles for pre- and posttreatment responses, respectively) along with the averaged day 1 
responses (mean shown as a dashed line with the SDs shown as shaded error bars). Vehicle-treated group, n = 3; 8 mg/kg MB-001–treated group, n = 2; 80 
mg/kg MB-001–treated group, n = 2; fenretinide-treated group, n = 3. Apart from a single animal in the high-dose MB-001 group (D), the pre- and postbleach 
responses in drug- and vehicle-treated animals were highly similar to the day 1 pretreatment responses. The greater responses in the single animal may have 
been caused by off-target drug toxicity.
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subtle effects of fenretinide on cone function are in line with 
clinical data showing that this compound has little impact on 
human cone function, even at high doses (Kaiser-Kupfer et al., 
1986; Marmor et al., 2008).
Collectively, these data demonstrate that cones rely on both 
continuous RPE65 activity and an independent second source of 
11-cis-retinaldehyde for regeneration of their visual pigments. 
The reduced ERG recovery rate that we observe in mice treated 
with RPE65 inhibitors when cone bleaching is achieved with a 
prolonged light exposure rather than a short step of light suggests 
a critical role for stored forms of 11-cis-retinoids in cone pigment 
regeneration. Indeed, the involvement of cellular 11-cis-retinal-
dehyde–binding protein (CRA LBP) in cone pigment regeneration 
has received considerable experimental support (Saari et al., 
2001; Collery et al., 2008; Fleisch et al., 2008; Xue et al., 2015). 
CRA LBP is expressed in the RPE and Müller glia (Bunt-Milam and 
Saari, 1983), where it noncovalently binds 11-cis-retinaldehyde 
as well as 11-cis-retinol with low nanomolar affinity (Saari et al., 
1982; Saari and Bredberg, 1987; Crabb et al., 1998). These cis-ret-
inoids can be released for rapid visual pigment regeneration 
(Saari and Crabb, 2005). In CRA LBP knockout (Rlbp1−/−) mice, 
rod dark adaptation after illumination is delayed >10-fold (Saari 
et al., 2001). Rlbp1−/− mice also exhibit defects in M-opsin cel-
lular distribution and consequently display M-cone dysfunction 
because of cis-retinoid deficiency, including greatly suppressed 
M-cone sensitivity and dark adaptation. These abnormalities can 
be rescued by selective reexpression of CRA LBP in Müller glia 
(Xue et al., 2015).
The contribution of CRA LBP toward intraretinal cone regen-
eration can be estimated. The quantity of this protein in the 
bovine neurosensory retina is ∼1 nmol/eye, and its molar ratio 
to rhodopsin is 1:20 (Stubbs et al., 1979). Assuming that (a) this 
ratio is similar in the mouse retina, (b) the amount of cone opsin 
in mouse retina is ∼1% of rhodopsin (Daniele et al., 2011), and (c) 
CRA LBP and 11-cis-retinoids form a 1:1 complex (Saari et al., 1982; 
He et al., 2009), we can estimate that there are on the order of 
five CRA LBP-associated 11-cis-retinoids per cone pigment stored 
in Müller cells.
Adding to this source of potential chromophore for the regen-
eration of cone pigments are 11-cis-retinyl esters found in vari-
able amounts in the RPE and neurosensory retina, depending on 
the species (Bridges et al., 1987; Rodriguez and Tsin, 1989; Das et 
al., 1992; Kaylor et al., 2013; Palczewska et al., 2014; Babino et al., 
2015; Mustafi et al., 2016). Ground squirrels in particular pos-
sess large quantities of 11-cis-retinyl esters in their neural retina 
(Mata et al., 2002), and this may account for the highly resilient 
responsiveness of their cones.
The availability of these stored forms of readily mobilized 
11-cis-retinoids, together with the ability of cones to operate 
over a wide dynamic range and with high degrees of baseline 
bleaching (Malchow and Yazulla, 1986; Jones et al., 1993), could 
explain the ability of these cells to maintain function in sustained 
bright light. Two important outstanding issues are the origin of 
11-cis-retinoids stored in the neural retina (i.e., derived from the 
classical vs. intraretinal visual cycle) and the necessity for ongo-
ing cis-retinoid production by the putative intraretinal visual 
cycle for cone-mediated vision.
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Figure S1. Schematic and validation of the DES1 activity assay. (A) DES1 dihydroceramide desaturase activity relies on NADH to provide electrons 
needed for production of an electrophilic, activated oxygen species that abstracts hydrogen from the substrate. The assay system uses a 3H-4,5–labeled 
synthetic dihydroceramide as a substrate. DES1 activity specifically releases tritium from the substrate as water, which is separated from unreacted sub-
strate and measured to quantify enzymatic activity. (B) Assessment of the linear range of the DES1 activity assay. Reactions were performed at 37°C for 0, 5, 
10, and 20 min in the presence of 30, 60, and 120 mg Lrat−/− mouse liver microsomes at a fixed substrate concentration of 0.5 µM. Under these conditions, 
the assay was relatively linear with respect to both time and enzyme concentration. (C) Steady-state kinetics of mouse liver DES1 activity toward C8-dihy-
droceramide. Assays were performed as described in the Materials and methods section with increasing concentrations of unlabeled C8-dihydroceramide 
and a fixed quantity of 4,5-3H-C8-dihydroceramide. Vmax and Km values of 10.7 ± 0.3 nmol/min/g and 0.50 ± 0.07 µM, respectively, were determined for this 
assay system based on a total number of 28 data points measured in three separate experiments spanning a range of C8-dihydroceramide concentrations 
from 0.011 to 10.4 µM.
Figure S2. Effects of RPE65 inhibitors on DES1 enzymatic function. DES1 dihydroceramide desaturase assays were performed according to the standard 
method in the presence of the indicated compounds at substrate concentrations below, at, and above the Km value for C8-dihydroceramide. The steady-state 
kinetic constants and the best fit mode of reversible inhibition derived from global curve fitting along with the estimated Ki values are shown in Table S1.
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Figure S3. Effects of MB-001 on dark-adapted mouse ERG responses. (A and B) ERG responses to a 1.65 log cd·s/m2 strobe flash recorded from mice 
(C57BL/6J, 2 mo old) that received IP DMSO vehicle or 8 mg/kg MB-001 immediately before, 22 h after, and 2 wk after a strong photobleach (10 min × 10,000 
lux). (C and D) Plots of the scotopic a-wave amplitudes for the two groups of mice. (E and F) Scotopic b-wave amplitudes for the two groups of mice. DMSO 
group, n = 4; MB-001 group, n = 3. The data are shown as means ± SEM.
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Figure S4. Impact of MB-001 treatment on ERG responses in ground squirrels after the multiday dosing schedule used in wild-type mice. (A and B) 
ERG responses from a single representative ground squirrel after vehicle (A) or MB-001 (B) treatment showing minimal effects of MB-001 treatment on cone 
function. ERG recordings were made in light-adapted 6-mo-old squirrels after 3 d of vehicle or MB-001 treatment before (left) and 10 min after (right) bleach-
ing (see Materials and methods) using a brief flash of variable intensity as stimulation (black arrows, three to five trials per flash intensity). During the 3 d of 
treatment, animals were housed in normal cyclical lighting conditions. (C and D) Treatment group averages of ERG responses, which do not reveal systematic 
differences between vehicle- and MB-001–treated animals. We obtained mean a-wave and b-wave amplitudes at each light intensity after normalization by 
the a-wave amplitude to the 4,000 cd·s/m2 flash before bleaching. We excluded responses to flash intensities <10 cd·s/m2 (shaded regions) because they 
were small and corrupted by noise. (E and F) Changes in ERG responses induced by bleaching are not significantly different between treatment groups using 
this original treatment schedule. We obtained mean a-wave and b-wave amplitude differences (prebleach response − postbleach response; n = 4 squirrels; 
error bars represent SEM) that show no significant differences at any light intensity between treatments. We compared these ratios as paired measurements 
(vehicle vs. MB-001) with Wilcoxon rank–sum tests using 5% as the significance level.
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Figure S5. Standard curve for MB-001 quantification. 2 nmol emixustat was spiked into a serial solution of MB-001 (0–2.4 nmol) in ethanol. 100 μl of the 
resulting solutions was injected into a liquid chromatography/mass spectrometry system. (A and B) The peak areas of emixustat chromatograms, recorded 
by selective reaction monitoring at m/z 264.2→246.2 (A) and MB-001 at m/z 304.2→257.2 (B), were recorded. (C) A standard curve depicting the ratio of the 
corresponding peak areas of MB-001 to emixustat and the ratio of their known amounts used in the experiment.
Kiser et al. 
Effects of retinoid cycle inhibition on cone vision
Journal of General Physiology
https://doi.org/10.1085/jgp.201711815
S25
Figure S6. Quantification of MB-001 levels in mouse and squirrel eyes. Eye extracts were dissolved in ethanol containing 2 nmol emixustat. 100 μl of 
the solution was injected into the liquid chromatography/mass spectrometry system. (A–D) The chromatogram obtained by selective reaction monitoring at 
m/z 304.2→257.2 demonstrated that the eyes of C57BL/6J mice (A) and ground squirrels (B) treated with MB-001 both contained substantial amounts of the 
compound, although the peaks of MB-001 in the eyes from the animals treated with DMSO were negligible (C and D). The amounts of MB-001 in both animals 
were calculated based on the standard curve shown in Fig. S5.
Table S1. Steady-state kinetic constants obtained for DES1-mediated dihydroceramide desaturase activity in the presence of RPE65 inhibitors
Concentration Emixustat MB-001 Ret-NH2
μM Vmax Km Vmax Km Vmax Km
400 4.4 0.35 6.1 0.21 4.9 6.1
200 6.8 0.47 10.5 0.37 10.4 2.7
100 7.5 0.37 11.9 0.39 13.9 1.4
50 8.4 0.38 10.6 0.33 8.6 0.40
0 9.6 0.37 8.3 0.30 10.3 0.47
Mode of inhibition Noncompetitive; Ki = 360 µM Noninhibitory Partial mixed or uncompetitive; Ki = 
∼80 µM
Vmax and Km values were derived by curve fitting as shown in Fig. S2. The bottom row shows the best fit mode of inhibition and associated Ki values derived 
from global analysis of the data. The activity simulation and minor inhibition of DES1 activity at higher concentrations precluded global fit analysis for 
MB-001.
